anxiety low mood
Conditions
Interventions
The intervention will be a guided web-based transdiagnostic intervention
targeted at symptoms of depression and/ or anxiety. The intervention consists
of 7 online sessions with duration ranging from
Sponsors
Vrije Universiteit
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: * subject must meet all of the following criteria: (a) participation in the niet-WMO study (2017.105) including consent to be contacted again for the RCT. (b) Being 18 years of age or older (c) Being enrolled as a student in a university or college in the Netherlands (d) Speak Dutch or English fluently (e) Students who experience mild to moderate depression (as defining by scoring above the cut-off score of 4 on the Patient health questionnaire [PhQ-9]) and/ or anxiety symptoms (as defining by scoring above the cut-off score of 4 on the Generalised Anxiety Disorder scale * 7 items [GAD * 7])
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in the RCT: (a) Risk for suicide according to the self-report measure (e-survey) (b) Co-morbid bipolar disorder according to the MINI diagnostic interview. (c) Students with severe depression (as defining by scoring above the cut-off score of 14 on the PhQ-9) and/ or anxiety symptoms (as defining by scoring above the cut-off score of 14 on the GAD-7 scale). (d) Currently receiving/ have received psychological treatment for depression and/or anxiety in the past 12 months (e) Having slow or no Internet connection (e.g. no broadband Internet or something comparable)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The endpoints of the RCT are the patient health questionnaire (PHQ-9) for depression and the Generalised Anxiety Disorder - 7 items scale (GAD-7) for anxiety. These scales will be administered at the screening (along with the e-survey), post-treatment and follow-up assessments (6 and 12 months post-randomisation). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoints are the Euroqol 5 Dimensions (EQ-5D) that will be administered at baseline, 6 and 12 months post-randomisation and the Client satisfaction with treatment * 8 items (CSQ-8) that will be administered at the post-treatment. | — |
Countries
Netherlands
Outcome results
None listed